WAGO Annual Meeting

2024 WAGO Annual Meeting
Save the Date — Wednesday, June 12 – Saturday, June 15
Seattle, Washington
Fairmont Olympic Hotel Seattle
4:00 PM – 7:30 PM
Registration Open
Exhibit & Poster Set-Up
6:00 pm – 7:30 pm
Welcome Reception
6:30 AM – 8:00 AM
Breakfast
6:30 PM – 12:00 PM
Registration Open
8:00 AM – 8:10 AM
Welcome & Opening Remarks
8:10 AM -9:15 AM
General Session 1
9:15 AM – 9:30 AM
Break
9:30 AM – 10:35 AM
General Session 2
10:35 AM – 12:05 PM
ASCO Update
Kathleen Moore, MD, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
12:05 PM – 1:50 PM
Industry Supported Symposium
5:30 PM – 7:00 PM
Networking Event
6:30 AM – 8:00 AM
Breakfast
6:30 AM – 2:00 PM
Registration Open
7:00 AM – 8:00 AM
Trainee Session
7:00 AM – 8:00 AM
WAGO Business Meeting
8:15 AM – 9:20 AM
General Session 3
9:20 AM – 9:35 AM
Break
9:35 AM – 10:25 AM
General Session 4
10:25 AM – 11:25 AM
Tumor Board
11:40 AM – 1:10 PM
Industry Supported Symposium
6:00 PM – 9:00 PM
President’s Reception
6:15 AM – 8:00 AM
Breakfast
6:15 AM – 12:00 PM
Registration Open
6:15 AM – 6:45 AM
Poster Presentations & Exhibit Hall Open
6:45 AM – 7:00 AM
WAGO 2025 Annual Meeting Location Announcement
7:00 AM – 8:00 AM
Presidential Lecture
8:30 AM – 9:20 AM
General Session 5
9:20 AM – 9:35 AM
Break
9:35 AM – 11:45 AM
General Session 6
11:45 AM – 11:55 AM
Closing Remarks
General Session 1
- HIV prevalence by age at a single institution providing cervical cancer screening and treatment for women in the Southern Region of Malaw
Presenting Author: Laurel Guthrie, MD, Loma Linda University - Acceptability of HPV self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal status
Presenting Author: Katherine Fitch, MD, Oregon Health & Sciences University - Development of a Student-Led Cervical Cancer Patient Education and Navigation Program
Presenting Author: Lindsey Finch, MD, Jackson Memorial Hospital - Patients with Disease Recurrence Report More Unmet Social Needs: An Evaluation Across the Gynecologic Cancer Continuum
Presenting Author: Katherine Cotangco, DO, University of California, Los Angeles
General Session 2
- Correlation of Clinical Outcomes and Poly ADP Ribose Polymerase Activity in High Grade Serous Ovarian Cancer
Presenting Author: Elaine Fleming, MD, University of Texas Southwestern Medical Center - Glucocorticoids Promote Granulosa Cell Tumor Growth and Antagonize Paclitaxel Via a FOXL2 c.C402G-dependent Mechanism
Presenting Author: Tyler Hillman, MD, PhD, UT MD Anderson Cancer Center - Shifting trends in diagnosis of high-grade serous tubo-ovarian carcinoma: a population-based assessment
Presenting Author: Matthew Lee, MD, University of Southern California - Post-operative care for patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): is there room to de-escalate post-operative care?
Presenting Author: Christianne Persenaire, MD, University of Colorado-Anschutz Medical Campus
General Session 3
- Aberrant beta-catenin distribution as potential prognosticator for endometrioid endometrial cancer recurrence
Presenting Author: Ashley Moon, MD, Stanford University School of Medicine - Therapeutic Utility of EC359 for Targeting LIFR Signaling in Type II Endometrial Cancer
Presenting Author: Nicole Spencer, MD, University of Texas Health Science Center San Antonio - Examining the immune tumor microenvironment of Endometrial Cancer patients treated with Pembrolizumab plus Lenvatinib
Presenting Author: Erica Carballo, MD, Vanderbilt University Medical Center - Pembrolizumab +/- Lenvatinib in Patients with advanced Endometrial Cancer in Northern California
Presenting Author: Tiffany Seto, MD, Kaiser Permanente San Francisco
General Session 4
- Immune related adverse events in endometrial cancer: A biomarker for treatment efficacy?
Presenting Author: Vinita Popat, MD, UT Southwestern Medical Center - Prognostic role of the molecular classification in endometrial cancer patients with cervical stromal invasion
Presenting Author: Fiorella Reyes-Baez, MD, Mayo Clinic - Patients with stage 1 endometrial cancer frequently do not receive guideline recommended postoperative radiation
Presenting Author: Christine Nguyen, MD, Oregon Health and Sciences University
General Session 5
- An assessment of changes in measures of quality of life and financial well-being over time among ovarian cancer patients
Presenting Author: Naomi Adjei, MD, MPH, MS, MD Anderson Cancer Center - How many lines is too many? Real world patterns of number of lines of chemotherapy in platinum resistant ovarian cancer
Presenting Author: Kelsey Goon, MD, University of Colorado - Crowdfunding pages identify unmet needs among gynecologic cancer patients
Presenting Author: Reed O’Connor, MD, PhD, Cedars-Sinai Medical Center - Patterns of Palliative Care Referral and Inpatient to Outpatient Palliative Care Transition in Gynecological Cancer Patients with a Focus on Primary Language: A Single Institution Retrospective Study
Presenting Author: Dandi Huang, MD, Cedar Sinai Medical Center
General Session 6
- Validation of a Hereditary Cancer Risk Assessment Scoring Tool for Use by Non-Genetics Trained Healthcare Workers
Presenting Author: Molly Zielenbach, MD, University of California, Los Angeles - Fertility outcomes in women with hereditary cancer syndromes
Presenting Author: Elizabeth Connelly, MD, Kaiser San Francisco - Hormone replacement therapy utilization over time following risk-reducing salpingo-oophorectomy in premenopausal patients at high risk for ovarian cancer
Presenting Author: Talayeh Ghezelayagh, MD, MPH, University of Washington - Utilization of care and alignment of screening with National Comprehensive Cancer Network Guidelines for patients with Lynch Syndrome
Presenting Author: Christina Lowry, MD, Kaiser San Francisco - Impact of Multi-variable Social Vulnerability on Cervical Cancer Prevention in Hispanic Women
Presenting Author: Eduardo Garcia, MD, University of California, Irvine - Association of anal dysplasia with cervical dysplasia and high-risk HPV subtypes in women
Presenting Author: Sonal Chaudhari, MD, University of California, Los Angeles - Help Wanted: Identifying and addressing sexual distress in newly referred gynecologic oncology patients
Presenting Author: Allyson Jang, MD, UCSF Helen Diller Family Comprehensive Cancer Center - Planned robotic-assisted interval hysterectomy for the management of placenta accreta spectrum
Presenting Author: Samantha Antonioli, MD, University of Texas Health Science Center at Houston, McGovern Medical School
Poster #1:
A Roadmap to Safety: Decreased Intraoperative Injury with a Multidisciplinary Approach to Placenta Accreta
Presenting Author: Rachel Levy, MD – UCSF
Poster #2:
COVID-19 vaccination in cancer patients receiving chemotherapy: does vaccination increase the risk of hypersensitivity reactions?
Presenting Author: Sierra M. Treiman, MD – Creighton Ob/Gyn Residency – Phoenix Campus
Poster #3:
Lenvatinib for Endometrial Cancer: Reducing Healthcare Disparities and Emphasizing Equitable Medication Access through Quality Improvement
Presenting Author: Steven Baine Holloway, MD, FACOG – UT Southwestern Medical Center
Poster #4:
An evidence-based approach to prescribing post-discharge opioids after laparotomy
Presenting Author: Allison H. Kay, MD – UCSF / KP SFO
Poster #5:
Effect of perioperative app on use of emergency medical services for patients recovering from laparotomy
Presenting Author: Megan Marshalla, MD – Rush University Medical Center
Poster #6:
Beyond Rounds—Improving Physician Wellness on the Gyn-Oncology Service through Meaningful Connection
Presenting Author: Nicole Rubin, MD – UCSF Division of Gynecologic Oncology
Poster #7:
If you don’t use it, lose it: Reducing over prescription of opioids at discharge
Presenting Author: Alison McGough-Madueña, MD, MPH – UCSF Division of Gynecologic Oncology
Poster #8:
Non-English language as a barrier to postoperative pain management
Presenting Author: Rachel Levy, MD – UCSF
Poster #9:
Two-year follow up on the impact of the COVID-19 pandemic on outcomes in gynecologic oncology patients
Presenting Author: Kati Turner, MD, MPH – Barnes-Jewish Hospital/Washington University in St. Louis
Poster #10:
Disparities in breast cancer screening adherence among Hispanic women who receive cervical cancer screening
Presenting Author: Grace R. Ge – McGovern Medical School at UTHealth Houston
Poster #11:
Planned Interim Analysis of a Randomized Trial Comparing Epidural to Surgical Site Infiltration with Liposomal Bupivacaine for Gynecologic Oncology Patients Undergoing Laparotomy
Presenting Author: Dana Hazimeh, MD – Johns Hopkins University – Department of GYN/OB
Poster #12:
Panniculectomy to Facilitate Minimally Invasive Hysterectomy is Effective for Severely Obese Patients Undergoing Gynecological Oncological Surgery
Presenting Author: Roxanne AR. Manek, DO – Kaiser Permenante
Poster #13:
Identifying Barriers to Initiation of Pelvic Floor Therapy: Life After Gynecologic Cancer
Presenting Author: Caroline Zhang, MD – University of Texas McGovern School of Medicine–UT Health
Poster #14:
Gynecologic and Breast Cancer Patient Experiences with Scalp Cooling to Reduce Alopecia
Presenting Author: Sujata Eden Tewari – St. Joseph Hospital, Orange, California
Poster #15:
Poor Self-Rated Mental Health Affected Cervical Cancer Screening Rates During the COVID-19 Pandemic
Presenting Author: Karen E. Haney, MD – University of Texas Health Science Center at Houston
Poster #16:
The Clot Thickens: Identifying Risk Factors for VTE in Metastatic and Recurrent Cervical Cancer
Presenting Author: Carson C. Edwards, MD – University of Texas Southwestern
Poster #17:
Do the Peters criteria hold up for adenocarcinoma? A retrospective database study evaluating the effect of histology on outcomes in surgically-treated high-risk early stage cervical cancer
Presenting Author: Danielle Greenberg, MD – University of California, Irvine
Poster #18:
Prognosis of cervical cancer when diagnosed during pregnancy
Presenting Author: Lydia M. Makepeace, MD – University of Texas at Southwestern Medical Center
Poster #19:
The impact of social media on anxiety and depression among patients with neuroendocrine carcinoma of the cervix: A Neuroendocrine Cervical Tumor Registry (NeCTuR) study
Presenting Author: Reem Saab, MD – The University of Texas MD Anderson Cancer Center
Poster #20:
Low-grade endometrioid endometrial cancer with adnexal metastasis: Possible de-escalation candidate for adjuvant therapy?
Presenting Author: Andrew Vallejo, MD – University of Southern California
Poster #21:
Use of postoperative opioids in patients undergoing robotic hysterectomy for endometrial cancer with or without abdominal wall block
Presenting Author: Ioana L. Bondre, MD – University of California San Diego
Poster #22:
Obese microenvironmental signaling and junctional protein disruption in endometrial cells: an early pro-oncogenic change?
Presenting Author: Megan E. Ross, MD, MPH – University of Texas Health Science Center San Antonio
Poster #23:
Immunotherapy in recurrent endometrial cancer: who derives benefit?
Presenting Author: Ayesha Kar-Kasal, MD – University of Chicago Medical Center
Poster #24:
Characterization of genomic and social determinants of health in the TP53 mutational landscape of non-cancerous endometrium during the lifespan of Black and White individuals
Presenting Author: Eric Rios-Doria, MD – University of Washington
Poster #25:
No survival difference in patients receiving radical hysterectomy vs. extrafascial hysterectomy in stage II-IV endometrial cancer patients – a multivariate analysis
Presenting Author: Teresa Palkowski, MD – UCSF Fresno
Poster #26:
Intraoperative radiation therapy in the treatment of recurrent cervical and endometrial cancer: analysis of postoperative complications
Presenting Author: Lindsay N. Howlett, BS – Mayo Clinic
Poster #27:
Attenuation of COVID-19 infection among patients with endometrial and cervical cancer receiving immunotherapy
Presenting Author: Natalie L. Shammas, MD – Adventist Health White Memorial Medical Center
Poster #28:
Decision-making regarding ovarian cancer risk-reduction among women of color who carry a BRCA mutation
Presenting Author: Emmeline Friedman, MD– University of New Mexico Health Sciences Center
Poster #29:
Clinical and pathological factors that predict survival in patients undergoing pelvic exenterations for gynecological malignancies
Presenting Author: Priyal P. Fadadu, MD, MS – Mayo Clinic
Poster #30:
HPV vaccination rates among women 27-45 rose more slowly after ACOG’s statement recommending shared decision making
Presenting Author: Ioana L. Bondre, MD – University of California San Diego
Poster #31:
Severe maternal morbidity is increased among pregnant persons with gynecological malignancies
Presenting Author: Katherine C. Fitch, MD – Oregon Health & Sciences University
Poster #32:
Evaluation of pseudoprogression on immune checkpoint inhibitor therapy in gynecologic cancers
Presenting Author: Adeola Akapo, MD – University of Colorado
Poster #33:
Characteristics and management of malignant mesonephric tumors of the female genital tract: a surveillance, epidemiology, and end results database study
Presenting Author: Danielle Greenberg, MD – University of California, Irvine
Poster #34:
Surgical outcomes for robotic-assisted single-site hysterectomy as compared to multi-site hysterectomy: a single institution retrospective study
Presenting Author: Ravali A. Reddy, MD – Stanford School of Medicine, Department of Obstetrics and Gynecology
Poster #35:
Trends in estimated percent of patients with epithelial ovarian cancer eligible for and responding to PARP inhibitors over time
Presenting Author: Erica V. Carballo, MD – Vanderbilt University Medical Center
Poster #36:
Somatic NF1 alterations as potential biomarker for response to immune checkpoint inhibition in recurrent ovarian cancer
Presenting Author: Ashley S. Moon, MD – Stanford University School of Medicine
Poster #37:
Assessment of malignancy type-specific COVID-19 case-fatality in the United States
Presenting Author: Andrew Vallejo, MD – University of Southern California
Poster #38:
Therapeutic Opportunities in the Master Transcription Factor Circuitries of Clear Cell Carcinomas
Presenting Author: Nolan J. Kinne, MD– Cedars Sinai Medical Center
Poster #39:
Comparison of contemporary management and outcomes of patients with transitional cell carcinomas and malignant Brenner tumors of the ovary
Presenting Author: Katherine Coakley, MD – University of California, San Diego
Poster #40:
Trends in ovarian cancer incidence and incidence-based mortality: a 15-year population-based analysis
Presenting Author: Sahana Somasegar, MD – Stanford University School of Medicine
Poster #41:
Overexpression of the microRNA let-7i does not consistently enhance sensitivity to cisplatin in vitro in patient-derived epithelial ovarian carcinoma samples
Presenting Author: Nora Badiner, MD – Loma Linda University Medical Center
Poster #42:
Chemical inhibition of SWI/SNF induces transformed growth in non-mutant cells, mimicking the effects of a SMARCA4 mutation associated with small cell carcinoma of the ovary, hypercalcemic type.
Presenting Author: Adam J. Krieg, PhD – OHSU/ONPRC
Poster #43:
UP-NEXT (ENGOT-Ov71-NSGO-CTU/GOG-3049): A Study of Upitifamab Rilsodotin (UpRi), a NaPi2b-directed Antibody Drug Conjugate (ADC) in Platinum-Sensitive Recurrent Ovarian Cancer
Presenting Author: Debra L. Richardson, MD, FACS, FACOG, Stephenson Cancer Center, OU Health
Poster #44:
In vitro chemosensitivity of patient-derived ovarian cancer samples is not correlated with homologous recombination deficiency, platinum sensitivity, or cancer stem cell frequency
Presenting Author: Nora Badiner, MD – Loma Linda University Medical Center
Poster #45:
Relative Incidence of Uterine Cancer in Black Patients Compared to White Patients in the US
Presenting Author: Deanna H. Wong, MD, MPH– UCLA
Poster #46:
Cancer Survival in Women Diagnosed with Leiomyosarcoma of the Uterus
Presenting Author: Christina Curtin, MD – University of Texas Southwestern
WAGO 2025 Annual Meeting
Wednesday, June 18 – Saturday, 21, 2025